Cancer antigen 27-29 (CA27-29) is a protein marker that can be used to detect and monitor the progress of certain types of cancer. It is most commonly associated with breast cancer, but it is also found in other cancers such as ovarian, lung, and gastric cancers. In this blog post, we will discuss the causes, symptoms and treatment for CA27-29 as well as how it is used to diagnose different types of cancer. We will also look at the latest research into this protein marker and explore potential new methods for detecting and monitoring the progression of different types of cancer.
Cancer antigen 27-29 (CA27-29) is a tumor marker for breast cancer. CA27-29 is found in the blood of some women with breast cancer. It may be used to help find breast cancer early. CA27-29 may also be used to see how well treatment is working or to check for breast cancer recurrence.
Cancer is a disease caused by the abnormal growth of cells in the body. Cancerous cells can grow and spread to other parts of the body, which can be life-threatening. The cause of cancer is not fully understood, but it is known that cancerous cells develop when there is a change in the genetic material of a cell. This change can be caused by exposure to certain substances, such as tobacco smoke or radiation. It can also be inherited from a person's parents. There are many different types of cancer, each with its own set of causes.
Cancer antigen (CA) 27-29 is a protein that is found on the surface of some cancer cells. It is used as a marker to help diagnose and monitor certain types of cancer. CA 27-29 levels may be elevated in people with breast, ovarian, or pancreatic cancer.
Elevated CA 27-29 levels may be a sign of cancer, but they can also occur in other conditions.
Additional symptoms that may be associated with CA 27-29 elevation include:
• Fatigue
• Weight loss
• Loss of appetite
• Nausea and vomiting
• Pain
• Jaundice (yellowing of the skin)
Cancer antigen (CA) 27-29 is a protein found on the surface of many types of cancer cells. It is used as a marker to help diagnose certain types of cancer, including ovarian cancer and breast cancer. CA 27-29 levels may also be increased in other conditions, such as benign (non-cancerous) tumors and certain inflammatory diseases.
Cancer antigen 27-29 is a protein that is produced by some types of cancer cells. It is used as a marker to help diagnose and monitor certain types of cancer. Cancer antigen 27-29 levels may be higher in people with:
-Lung cancer
-Breast cancer
-Ovarian cancer
-Colorectal cancer
Cancer antigen 27-29 levels can be measured with a blood test. If the levels are high, it may be an indication that the cancer is present or returning. Treatment for cancer usually involves surgery, chemotherapy, and/or radiation therapy.
Cancer antigen 27-29 is a protein that is produced by some types of cancer cells. This protein can be detected in the blood of people with certain types of cancer, such as ovarian cancer. Cancer antigen 27-29 is not a specific marker for any one type of cancer, but it may be useful in detecting early stage ovarian cancer and other cancers. There is no specific treatment for cancer antigen 27-29, but it is important to detect and treat the underlying cancer as soon as possible.
In conclusion, cancer antigen 27-29 is a protein produced by certain types of cancers and can be used as a marker to diagnose the presence of these diseases. With early diagnosis and proper treatment, cancer caused by CA27-29 may have an improved prognosis. We hope this article has provided you with more information about what CA27-29 is, its causes, symptoms and how it can be treated.
1.
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.
2.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
3.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
4.
Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma
5.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
1.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
2.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
3.
Blood Donation Sustainability Through Behavioral Science
4.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
5.
Essential Developments in Oncology for Healthcare Excellence
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation